Morningstar
•
May 29, 2026
ICON Public Limited Company: Icon Earnings: Accounting Overhang Lifted, Underlying Demand Trends Encouraging as Shares Soar 15%
Summary
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon’s services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Mettler-Toledo International Inc.
May 28, 2026
•
MTD
The Argus Sustainable Growth Theme Model Portfolio
May 28, 2026
•
TT, DE, GOOGL, AAPL, NDAQ, AVGO, JPM, ADI, MRK, JNJ, TXN, TFC, MSFT, GLW, MA, LLY, SPGI, TRV, GE, NVDA, NOC, KO, KMI, AEP, GS, ECL, TMUS, AMZN, ETN, WMT
Analyst Report: Insulet Corporation
May 27, 2026
•
PODD
MEDP: Raising target price to $477.00
May 27, 2026
•
MEDP
WST: Raising target price to $348.00
May 27, 2026
•
WST
